S-1 Filing

The new SPAC intends to focus on businesses that have their primary operations in FinTech, financial services, business services, technology, consumer goods and other new economy industries.

The SPAC said in its original S-1 filing that it would focus on opportunities in biotechnology and green technology industries with an emphasize on ESG.

The SPAC intends to focus on target businesses in the infrastructure, E&C, industrial and renewables industries. 

The new SPAC plans to focus on the biotechnology and pharmaceutical sectors, including potential targets in China. 

The sponsor's other SPACs include FG Merger II, which filed for a $75 million raise in October, and FG Merger, which completed a deal with healthcare software firm iCoreConnect in August.

Blue Room said it will target companies in the financial sector.

The new SPAC is broadly focused on consumer goods, sports and entertainment, and healthcare technology.

The SPAC intends to pursue a business combination with a company in Asia, including China.

The offering was initially registered in February 2021.

The SPAC in its original S-1 filing said it would target “high growth target businesses that are headquartered in Latin America and are operating within sectors that have significant unmet demand.”